INCREASED PLASMA FIBRONECTIN IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:6
|
作者
NISHINARITA, S
YAMAMOTO, M
TAKIZAWA, T
HAYAKAWA, J
KARASAKI, M
SAWADA, S
机构
[1] First Department of Medicine, Nihon University, School of Medicine, Tokyo, Itabashi ku
关键词
Fibronectin; Mononuclear Phagocytic System; Systemic Lupus Erythematosus;
D O I
10.1007/BF02031971
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To add to our knowledge of collagen diseases, plasma fibronectin (FN) in patients with systemic lupus erythematosus (SLE) has been measured, and it was determined that the plasma FN value in those with SLE was 454±36 μg/ml, is significantly higher than the FN value in normal subjects (234±21 μg/ml. Further, the plasma FN value of patients with active SLE was significantly higher (591±46 μg/ml than that of patients with non-active SLE (287±31 μg/ml. The plasma FN value of SLE patients was also seen to be associated with the peripheral blood platelet count and with the dose level of the corticosteroid hormone administered to patients. In active SLE patients, it was similarly found that the plasma FN value had a significant correlation with the peripheral blood lymphocyte count and with the dose level of the corticosteroid hormone given to patients. Since the plasma FN value is known to be high in untreated SLE patients, it was felt that the increase of the FN value in SLE patients is not due to the effect of the corticosteroid but to the disease itself. © 1990 Springer-Verlag.
引用
收藏
页码:214 / 219
页数:6
相关论文
共 50 条
  • [1] CRYOGLOBULINEMIA AND FIBRONECTIN IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BARANAUSKAITE, AA
    NASONOV, EL
    EFREMOV, EE
    KURMANOVA, LV
    EREMEEVA, MV
    SOLOVYOV, SK
    KOVALEV, VY
    LOPAEVA, OV
    KOBYLYANSKY, AG
    TERAPEVTICHESKII ARKHIV, 1991, 63 (05) : 75 - 78
  • [2] INCREASED RISK OF CANCER IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    PETTERSSON, T
    PUKKALA, E
    TEPPO, L
    FRIMAN, C
    ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (04) : 437 - 439
  • [3] INCREASED BLOOD AND PLASMA VISCOSITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    HAZELTON, RA
    LOWE, GDO
    FORBES, CD
    STURROCK, RD
    JOURNAL OF RHEUMATOLOGY, 1985, 12 (03) : 616 - 617
  • [4] LUPUS ANTICOAGULANT AND INCREASED THROMBIN GENERATION IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    FERRO, D
    QUINTARELLI, C
    VALESINI, G
    VIOLI, F
    BLOOD, 1994, 83 (01) : 304 - 304
  • [5] PLASMINOGEN ACTIVATION IN PLASMA OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    NEGORO, N
    KANAYAMA, Y
    TAKEDA, T
    FUJISAWA, M
    OKAMURA, M
    INOUE, T
    RHEUMATOLOGY INTERNATIONAL, 1989, 8 (06) : 273 - 277
  • [6] IMMUNOADSORBENT PLASMA PERFUSION IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    SCHNEIDER, M
    BERNING, T
    WALDENDORF, M
    GLASER, J
    GERLACH, U
    JOURNAL OF RHEUMATOLOGY, 1990, 17 (07) : 900 - 907
  • [7] PLASMA GLYCOSAMINOGLYCANS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    FRIMAN, C
    NORDSTROM, D
    ERONEN, I
    JOURNAL OF RHEUMATOLOGY, 1987, 14 (06) : 1132 - 1134
  • [8] INCREASED LEVELS OF NGF IN SERA OF SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS
    BRACCILAUDIERO, L
    ALOE, L
    LEVIMONTALCINI, R
    GALEAZZI, M
    SCHILTER, D
    SCULLY, JL
    OTTEN, U
    NEUROREPORT, 1993, 4 (05) : 563 - 565
  • [9] INCREASED MONOCYTE PROCOAGULANT ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    TERNISIEN, C
    OLLIVIER, V
    CHOLLETMARTIN, S
    DEPROST, D
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1990, 32 (05): : 373 - 375
  • [10] LACK OF INCREASED HYPERSENSITIVITY TO PENICILLIN IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    VONMAUR, K
    TURK, A
    STEVENS, MB
    ADKINSON, NF
    LICHTENS.LM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1974, 53 (02) : 68 - 68